DE69629576D1 - Verfahren zur herstellung von rekombinanten plasmiden - Google Patents
Verfahren zur herstellung von rekombinanten plasmidenInfo
- Publication number
- DE69629576D1 DE69629576D1 DE69629576T DE69629576T DE69629576D1 DE 69629576 D1 DE69629576 D1 DE 69629576D1 DE 69629576 T DE69629576 T DE 69629576T DE 69629576 T DE69629576 T DE 69629576T DE 69629576 D1 DE69629576 D1 DE 69629576D1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- genetic material
- culture system
- toxic
- plasmids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000013612 plasmid Substances 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- 241000206602 Eukaryota Species 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 230000002759 chromosomal effect Effects 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54805995A | 1995-10-17 | 1995-10-17 | |
US548059 | 1995-10-17 | ||
US56497395A | 1995-11-30 | 1995-11-30 | |
US564973 | 1995-11-30 | ||
PCT/CA1996/000693 WO1997014805A2 (en) | 1995-10-17 | 1996-10-17 | Methods for production of recombinant plasmids |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69629576D1 true DE69629576D1 (de) | 2003-09-25 |
DE69629576T2 DE69629576T2 (de) | 2004-06-24 |
Family
ID=27068752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69629576T Expired - Fee Related DE69629576T2 (de) | 1995-10-17 | 1996-10-17 | Verfahren zur herstellung von rekombinanten plasmiden |
Country Status (9)
Country | Link |
---|---|
US (1) | US5922583A (de) |
EP (1) | EP0856059B1 (de) |
JP (1) | JPH11513562A (de) |
AT (1) | ATE247713T1 (de) |
AU (1) | AU7208896A (de) |
CA (1) | CA2232234A1 (de) |
DE (1) | DE69629576T2 (de) |
TW (1) | TW514667B (de) |
WO (1) | WO1997014805A2 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1006085A3 (fr) * | 1992-07-31 | 1994-05-10 | Univ Bruxelles | Vecteur de clonage. |
DK1075512T3 (da) * | 1998-05-07 | 2010-06-07 | Univ Bruxelles | Cytotoxinbaseret biologisk indkapsling |
AU1031900A (en) * | 1998-11-09 | 2000-05-29 | Genecare Development Aps | Novel plasmids for use in medicine and method of producing same |
US8076130B2 (en) * | 1998-12-02 | 2011-12-13 | University Of Maryland, Baltimore | Plasmid maintenance system for antigen delivery |
NZ529507A (en) * | 1998-12-02 | 2005-05-27 | Univ Maryland | Plasmid maintenance system for antigen delivery |
US6413768B1 (en) | 1998-12-02 | 2002-07-02 | University Of Maryland | Expression plasmids |
US6423545B1 (en) * | 1999-07-08 | 2002-07-23 | Albert Einstein College Of Medicine Of Yeshiva University | Unmarked deletion mutants of mycobacteria and methods of using same |
EP1111061A1 (de) * | 1999-12-20 | 2001-06-27 | Universite Libre De Bruxelles | Vektor mit doppelter Selektion |
US9012141B2 (en) * | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
JP5442177B2 (ja) * | 2001-02-23 | 2014-03-12 | ユニベルスィテ リーブル ドゥ ブリュッセル | 毒性分子に対する抗毒性蛋白質をコードする配列を含む組換体クローンの選択方法 |
US7396822B2 (en) | 2001-05-24 | 2008-07-08 | Vaxiion Therapeutics, Inc. | Immunogenic minicells and methods of use |
US20030194798A1 (en) | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
US20030224444A1 (en) * | 2002-02-25 | 2003-12-04 | Sabbadini Roger A. | Antibodies to native conformations of membrane proteins |
US20030207833A1 (en) * | 2002-02-25 | 2003-11-06 | Neil Berkley | Pharmaceutical compositions with minicells |
US20030224369A1 (en) * | 2002-02-25 | 2003-12-04 | Surber Mark W. | Reverse screening and target identification with minicells |
CA2477194A1 (en) * | 2002-03-19 | 2003-09-25 | Universite Libre De Bruxelles | Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
US20040005700A1 (en) * | 2002-05-28 | 2004-01-08 | Surber Mark W. | Poroplasts |
US9309518B2 (en) | 2002-09-03 | 2016-04-12 | Universite Libre De Bruxelles | Reversible, parallel and multitask cloning method and kit |
ATE383421T1 (de) * | 2002-09-03 | 2008-01-15 | Univ Bruxelles | Reversible, parallele und zur vielfältigen aufgabenbewältigung verwendbare (multitask) klonierungsmethode und entprechende reagentien |
GB0327056D0 (en) * | 2003-11-20 | 2003-12-24 | Cobra Biolog Ltd | Plasmid maintenance |
US20060002956A1 (en) * | 2004-04-05 | 2006-01-05 | Surber Mark W | Minicells as vaccines |
ES2543079T3 (es) | 2004-08-13 | 2015-08-14 | The Trustees Of The University Of Pennsylvania | Métodos para construir vacunas sin resistencia antibiótica |
TWI311152B (en) * | 2004-09-17 | 2009-06-21 | Boehringer Ingelheim Rcv Gmbh & Co K | Host-vector system for antibiotic-free cole1 plasmid propagation |
CN1912127B (zh) * | 2005-08-08 | 2011-05-25 | 百瑞全球有限公司 | 一种大肠杆菌表达载体及其应用 |
US9109012B2 (en) | 2007-05-29 | 2015-08-18 | Nature Technology Corporation | Vectors and method for genetic immunization |
US9084747B2 (en) * | 2009-11-11 | 2015-07-21 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors |
US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
US20120135033A1 (en) * | 2008-05-19 | 2012-05-31 | Anu Wallecha | Multiple delivery system for heterologous antigens |
EP2288379A4 (de) | 2008-05-19 | 2012-08-08 | Advaxis | Doppeltes freisetzungssystem für heterologe antigene |
US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
JP5981436B2 (ja) | 2010-10-01 | 2016-08-31 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 寄生的に感染している対象におけるワクチン不応答性を反転させるためのリステリアワクチンベクターの使用 |
JP6199746B2 (ja) | 2011-02-15 | 2017-09-20 | バキシオン セラピューティクス,リミテッド ライアビリティ カンパニー | 抗体およびFc含有標的化分子に基づく生理活性分子の標的送達のための細菌ミニ細胞による治療用組成物および方法 |
CA2829960A1 (en) | 2011-03-11 | 2012-09-20 | John Rothman | Listeria-based adjuvants |
BR112014022662A2 (pt) | 2012-03-12 | 2017-10-03 | Advaxis Inc | Inibição da função de célula supressora seguindo tratamento de vacina de listeria |
CA2883227A1 (en) | 2012-08-29 | 2014-03-06 | Nature Technology Corporation | Dna plasmids with improved expression |
US20150322439A1 (en) | 2012-11-19 | 2015-11-12 | Nature Technology Corporation | Replicative minicircle vectors with improved expression |
BR122021015417B1 (pt) | 2013-08-19 | 2022-11-08 | Syngulon Sa | Célula microbiana geneticamente engenheirada que compreende um ácido nucleico que codifica uma bacteriocina |
ES2821655T3 (es) | 2017-09-19 | 2021-04-27 | Deutsches Krebsforsch | Vectores de ADN no integrantes para la modificación genética de células |
WO2019057774A1 (en) | 2017-09-19 | 2019-03-28 | Deutsches Krebsforschungszentrum | NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS |
US11932672B2 (en) | 2017-12-19 | 2024-03-19 | Syngulon S.A. | Fermentation process |
JP2021518150A (ja) | 2018-03-21 | 2021-08-02 | ネイチャー テクノロジー コーポレーション | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4968619A (en) * | 1976-09-27 | 1990-11-06 | Research Corporation | Modified microorganisms and method of preparing and using same |
US4190495A (en) * | 1976-09-27 | 1980-02-26 | Research Corporation | Modified microorganisms and method of preparing and using same |
US4550081A (en) * | 1980-05-19 | 1985-10-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Non-reverting salmonella |
US4837151A (en) * | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
US5077044A (en) * | 1980-05-19 | 1991-12-31 | The Board Of Trustees Of The Leland Stanford Jr. University | Novel non-reverting shigella live vaccines |
US5210035A (en) * | 1980-05-19 | 1993-05-11 | Board Of Trustees Of Leland Stanford Jr. University | Non-reventing live vaccines |
US4888170A (en) * | 1981-10-22 | 1989-12-19 | Research Corporation | Vaccines obtained from antigenic gene products of recombinant genes |
US5702916A (en) * | 1982-09-16 | 1997-12-30 | Gx Biosystems A/S | Biological Containment |
DK410783D0 (da) * | 1982-09-16 | 1983-09-09 | Benzon A Salfred | Fremgangsmade til stabilisering af plasmider |
FR2568891B1 (fr) * | 1984-08-09 | 1988-05-27 | Transgene Sa | Procede de preparation d'une souche, notamment de levure, transformee par un vecteur d'expression, qui peut etre cultivee sur un milieu complet sans pression de selection et souche ainsi obtenue |
DK594084A (da) * | 1984-12-12 | 1986-06-13 | Novo Industri As | Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning |
DK275685D0 (da) * | 1985-06-18 | 1985-06-18 | Benzon As Alfred | Stabilisering af biologiske systemer |
GB2177097A (en) * | 1985-06-18 | 1987-01-14 | Genencor Inc | Stable maintenance of nucleic acid in recombinant cells |
US5294441A (en) * | 1987-06-04 | 1994-03-15 | Washington University | Avirulent microbes and uses therefor: salmonella typhi |
IL86583A0 (en) * | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
US5387744A (en) * | 1987-06-04 | 1995-02-07 | Washington University | Avirulent microbes and uses therefor: Salmonella typhi |
ATE121785T1 (de) * | 1987-10-07 | 1995-05-15 | Univ Washington | Verfahren zur erhaltung eines erwünschten rekombinanten gens in einer genetischen zellpopulation. |
CA1339307C (en) * | 1988-09-06 | 1997-08-19 | Roy Curtiss, Iii | Oral immunization by transgenic plants |
WO1990011688A1 (en) * | 1989-03-31 | 1990-10-18 | Washington University | Avirulent microbes and uses therefor |
IL93957A0 (en) * | 1989-03-31 | 1990-12-23 | Univ Washington | Bordetella outer membrane proteins,their use in vaccines and their expression |
JP3004049B2 (ja) * | 1989-03-31 | 2000-01-31 | ワシントン ユニバーシティー | 病原性のないphoP型微生物を含有するワクチン |
US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
WO1991006317A1 (en) * | 1989-11-03 | 1991-05-16 | Washington University | Cross-protective salmonella vaccines |
DE69131014T2 (de) * | 1990-11-21 | 1999-10-07 | Univ St Louis | Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe |
WO1994024291A2 (en) * | 1993-04-15 | 1994-10-27 | Washington University | Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation |
-
1996
- 1996-10-16 US US08/732,612 patent/US5922583A/en not_active Expired - Fee Related
- 1996-10-17 CA CA002232234A patent/CA2232234A1/en not_active Abandoned
- 1996-10-17 JP JP9515377A patent/JPH11513562A/ja not_active Ceased
- 1996-10-17 AU AU72088/96A patent/AU7208896A/en not_active Abandoned
- 1996-10-17 WO PCT/CA1996/000693 patent/WO1997014805A2/en active IP Right Grant
- 1996-10-17 DE DE69629576T patent/DE69629576T2/de not_active Expired - Fee Related
- 1996-10-17 AT AT96933294T patent/ATE247713T1/de not_active IP Right Cessation
- 1996-10-17 EP EP96933294A patent/EP0856059B1/de not_active Expired - Lifetime
- 1996-12-24 TW TW085115998A patent/TW514667B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1997014805A2 (en) | 1997-04-24 |
CA2232234A1 (en) | 1997-04-24 |
DE69629576T2 (de) | 2004-06-24 |
AU7208896A (en) | 1997-05-07 |
EP0856059A1 (de) | 1998-08-05 |
EP0856059B1 (de) | 2003-08-20 |
US5922583A (en) | 1999-07-13 |
TW514667B (en) | 2002-12-21 |
JPH11513562A (ja) | 1999-11-24 |
ATE247713T1 (de) | 2003-09-15 |
WO1997014805A3 (en) | 1997-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69629576D1 (de) | Verfahren zur herstellung von rekombinanten plasmiden | |
Blackman et al. | The role of autolysins during vegetative growth of Bacillus subtilis 168 | |
Criado et al. | A single amino acid near the C terminus of the synaptosomeassociated protein of 25 kDa (SNAP-25) is essential for exocytosis in chromaffin cells | |
WO1997014809A3 (en) | Novel expression vectors and methods of use | |
Atkinson et al. | Activation of the glnA, glnK, and nac promoters as Escherichia coli undergoes the transition from nitrogen excess growth to nitrogen starvation | |
DE69633228D1 (de) | Botulinumtoxinderivate die periferishe sensorische afferende funktionen ändern können | |
DK0851868T3 (da) | Höjniveau-ekspression af proteiner | |
DE69632827D1 (de) | Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen | |
DE69128893D1 (de) | Genetische veränderung von endothelzellen | |
AU4703796A (en) | Stable lipid-comprising drug delivery complexes and methods for their production | |
IN189732B (de) | ||
HUP9900868A2 (hu) | Heterológ gének kromoszomális expressziója bakteriális sejtekben | |
WO2002029083A3 (en) | Industrial-scale serum-free production of recombinant proteins in mammalian cells | |
Steinberg | The cellular roles of molecular motors in fungi | |
HUT76556A (en) | Novel agent for controlling cell activity | |
RU94034733A (ru) | Способ получения клонирования и экспрессии гена, гены, иммунотоксины, продукты генов, днк, клетка, способ проверки гена и способ коррекции мутаций | |
AU2003222717A1 (en) | Streptavidin-binding peptide | |
DE69906509D1 (de) | Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen | |
TR200000288T2 (tr) | İnsülin C-peptidin rekombinan ekspresyonu. | |
CA2159079A1 (en) | Methods and DNA Expression Systems for Over-Expression of Proteins in Host Cells | |
DE59508100D1 (de) | Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander | |
Engels et al. | Influence of cultivation conditions on the production of staphylocoagulase by Staphylococcus aureus 104 | |
Ball | Gentics and Breeding of Industrial Microorganisms | |
ATE49998T1 (de) | Klonierungsvektoren, die eine restriktionsstellenbank enthalten und deren herstellung. | |
DK0801682T3 (da) | Fremgangsmåde til fremstilling af proteiner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |